参考文献/References:
[l] Curnis F,Arrigoni G,Sacehi A,et al.Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels,epithelia,and myeloid cells.Cancer Res,2002,62(3):867-874.
[2] Bhagwat SV,Lahdenranta J,Giordano R,et al.CD13/APN is activated by angiogenic signals and is essential for capillary tube formation.Blood,2001,97(3):652-659.
[3] Bhagwat SV,Petrovic N,Okamoto Y,et al.The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis.Blood,2003,101(5):1818-1826.
[4] 吴旭辉.CD13靶向治疗研究进展.癌症进展,2006,4(2):163-166.
[5] Corti A,Curnis F,Arap W,et al.The neovasculature homing motif NGR:more than meets the eye.Blood,2008,112(7):2628-2635.
[6] Pasqualini R,Koivunen E,Kain R,et al.Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.Cancer Res,2000,60(3):722-727.
[7] Di Matteo P,Arrigoni GL,Alberici L,et al.Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues.J His-tochem Cytochem,2011,59(1):47-59.
[8] Carmeliet P.Angiogenesis in life,disease and medicine.Nature,2005.438(7070):932-936.
[9] Carmeliet P,Jain RK.Angiogenesis in cancer and other diseases.Nature.2000,407(6801):249-257.
[10] Fukasawa K Fujii H,Saitoh Y,et al.Aminopeptidase N(APN/CD13) is selectively expressed in vascular endothelial cells and plays mul-tiple role in angiogenesis.Cancer Lett,2006,243(1):135-143.
[11] Oostendorp M,Douma K,Wagenaar A,et al.Molecular magnetic resonance imaging of myocardial angiogenesis after acute myocardial infarction.Circulation,2010,121(6):775-783.
[12] Oostendorp M,Douma K,Hackeng TM,et al.Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots.Cancer Res,2008,68(18):7676-7683.
[13] Petrovic N,Schacke W,Gabagan JR,et al.CD13/APN regulates endothelial invasion and filopedia formation.Blood,2007,110(1):142-150.
[14] Petrovic N,Bhagwat SV,Ratzan WJ,et al.CD13/APN transcription is induced by RAS/MAPK-mediated phosphorylation of Ets-2 in activated endothelial cells.J Biol Chem,2003,278(49):49358-49368.
[15] Ikeda N,Nakajima Y,Tokuhara T,et al.Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma.Clin Cancer Res,2003,9(4):1503-1508.
[16] Tokuhara T,Hattori N,Ishida H,et al.Clinical significiance of aminopeptidase N in non-small cell lung cancer.Clin Cancer Res,2006,12(13):3971-3978.
[17] Buehler A,van Zandvoort MA,Stelt BJ,et al.cNGR:a novel horning sequence for CD13/APN targeted molecular imaging of murine cardiac angiogenesis in vivo.Arterioscler Thromb Vasc Biol,2006,26(12):2681-2687.
[18] Curnis F,Gasparri A,Sacchi A,et al.Targeted delivery of IFN gamma to tumor vessels uncouples antitumor from counter regulatory mechanisms.Cancer Res,2005,65(7):2906-2913.
[19] Sacchi A,Gasparri A,Curnis F,et al.Crucial role for interferon gamma in the synergism between tumor vaseulature-targeted tumor necrosis factor alpha(NGR-TNF) and doxorubicin.Cancer Res,2004,64(19):7150-7155.
[20] Curnis F,Sacchi A,Gasparri A,et al.Isoaspartate-glycine-arginine:a new tumor vasculature-targeting motif.Cancer Res,2008,68(17):7073-7082.
相似文献/References:
[1]夏俊勇,王火强.以血管内皮生长因子及其受体为靶向的肺癌放射性核素显像[J].国际放射医学核医学杂志,2008,32(2):82.
XIA Jun-yong,WANG Huo-qiang.Lung cancer radionuclide imaging targeting at vascular endothelial growth factor and its receptor[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(6):82.
[2]黄建敏,解朋,刘晓梅,等.以整合素αvβ3为靶点的肿瘤分子显像及靶向治疗[J].国际放射医学核医学杂志,2015,39(3):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
Huang Jianmin,Xie Peng,Liu Xiaomei,et al.Integrins αvβ3 in molecular imaging and targeted therapy of neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
[3]郝玉美,贺欣,宋娜玲.靶向肿瘤新生血管整合素αvβ3受体显像研究现状及进展[J].国际放射医学核医学杂志,2014,38(3):179.[doi:10.3760/cma.j.issn.1673-4114.2014.03.010]
Hao Yumei,He Xin,Song Naling.Progress on tumor angiogenesis imaging targeting integrin αvβ3 receptor[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):179.[doi:10.3760/cma.j.issn.1673-4114.2014.03.010]
[4]张一秋,石洪成.肝细胞癌肿瘤新生血管影像学评价的研究进展[J].国际放射医学核医学杂志,2013,37(1):60.[doi:10.3760/cma.j.issn.1673-4114.2013.01.015]
ZHANG Yi-qiu,SHI Hong-cheng.Advances in assessment of imaging examination for tumor neoangiogenesis induced by hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):60.[doi:10.3760/cma.j.issn.1673-4114.2013.01.015]
[5]陈敏,魏玲格,刘晓梅.肿瘤血管生成的分子影像学研究进展[J].国际放射医学核医学杂志,2012,36(2):65.[doi:10.3760/cma.j.issn.1673-4114.2012.02.001]
CHEN Min,WEI Ling-ge,LIU Xiao-mei.Advances of molecular imaging in tumor angiogenesis[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(6):65.[doi:10.3760/cma.j.issn.1673-4114.2012.02.001]
[6]潘秀花,杨占山.促血管生成素的功能及应用进展[J].国际放射医学核医学杂志,2006,30(1):53.
PAN Xiu-hua,YANG Zhan-shan.The progress of the function and application about angiopoietion[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(6):53.